Clinical Trials in Pennsylvania

Showing 6961-6980 of 14,950 trials

COVID-19 Booster Readiness Survey

NCT05529030

The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.

Vaccination Refusal

Geisinger Clinic12,036 participantsStarted Sep 2022

Danville, Pennsylvania, United States

COMPLETEDPhase 345 miles

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

NCT02544763

This trial consists of 2 parts: a double-blinded phase and an open-label extension phase. The blinded phase only will be described in this record. Participants will receive 1 of 2 doses of GWP42003-P or matching placebo. The primary clinical hypothesis is that there will be a difference between GWP42003-P and placebo in their effect on seizure frequency.

Tuberous Sclerosis ComplexSeizures

Jazz Pharmaceuticals224 participantsStarted Apr 2016

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +41 more locations

COVID-19 Booster Readiness Survey

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Find Trials by Condition in Pennsylvania

Defense Health Agency- Development of a Medical Device Utilizing an EEG-Based Algorithm for the Objective Quantification of Pain

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

Natural History of Optic Neuritis

Dysport® Adult Lower Limb Spasticity Study

The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Dysport® Adult Upper Limb Spasticity Extension Study

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

StatStrip Glucose/Ketone Meter System Ketone Evaluation